FLGT Q2 2023 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q2 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$68M-45.9% YoY

Gross Profit

$21M30.3% margin

Operating Income

-$20M-29.2% margin

Net Income

-$11M-16.5% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+2.5%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

-$2M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$91M

Stockholders' Equity

$1.3B

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68M	$125M	-45.9%
Gross Profit	$21M	$65M	-68.5%
Operating Income	-$20M	$13M	-254.7%
Net Income	-$11M	$12M	-197.3%

Geographic Segments

UNITED STATES

$63M93%

Non-US

$5M7%